NOVOCURE LTD - NOTE 11/0

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Debt / NOTE 11/0
Market price (% of par)
91.13%
Total 13F principal
$546,744,600
Principal change
+$24,260,920
Total reported market value
$502,538,798
Number of holders
44
Value change
+$13,433,131
Number of buys
26
Number of sells
23

Institutional Holders of NOVOCURE LTD - NOTE 11/0 as of Q1 2022

As of 31 Mar 2022, NOVOCURE LTD - NOTE 11/0 was held by 44 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $546,744,600 in principal (par value) of the bond. The largest 10 bondholders included WOLVERINE ASSET MANAGEMENT LLC, Allianz Asset Management GmbH, STEELHEAD PARTNERS LLC, DeepCurrents Investment Group LLC, Verition Fund Management LLC, D. E. Shaw & Co., Inc., BANK OF AMERICA CORP /DE/, CAPSTONE INVESTMENT ADVISORS, LLC, Balyasny Asset Management LLC, and Aequim Alternative Investments LP. This page lists 45 institutional bondholders reporting positions for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.